Back to Search Start Over

Clinical guidelines ‘Hyperprolactinemia’ (draft)

Authors :
I. I. Dedov
G. A. Melnichenko
L. K. Dzeranova
E. N. Andreeva
E. N. Grineva
E. I. Marova
N. G. Mokrysheva
E. A. Pigarova
S. Y. Vorotnikova
N. S. Fedorova
A. S. Shutova
E. G. Przhiyalkovskaya
I. A. Ilovaуskaya
T. I. Romantsova
S. A. Dogadin
L. A. Suplotova
Source :
Ожирение и метаболизм, Vol 20, Iss 2, Pp 170-188 (2023)
Publication Year :
2023
Publisher :
Endocrinology Research Centre, 2023.

Abstract

Hyperprolactinemia is a persistent excess of the blood serum prolactin. The syndrome contains various symptoms, the most characteristic is a violation of the reproductive system. There are multiple endogenous and exogenous causes of hyperprolactinemia. The main treatment method is dopamine agonist therapy, in case of prolactinoma existence, surgical and radiation methods can be applied. About 15% of patients are resistant to dopamine agonist therapy, which determines creation of individual management tactics. The article presents a draft of clinical guidelines for the diagnosis and treatment of hyperprolactinemia, which provides a modern examination algorithm, discusses the basic principles of diagnostics and treatment approaches.

Details

Language :
English, Russian
ISSN :
20718713 and 23065524
Volume :
20
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Ожирение и метаболизм
Publication Type :
Academic Journal
Accession number :
edsdoj.66ae6be2b924d338bf260ee24a3b32a
Document Type :
article
Full Text :
https://doi.org/10.14341/omet13002